Prosecution Insights
Last updated: August 06, 2026
Application No. 18/958,213

APPARATUS AND METHOD FOR CELL KILL CONFIRMATION

Non-Final OA §101§DP
Filed
Nov 25, 2024
Priority
Jun 15, 2018 — provisional 62/685,614 +3 more
Examiner
KIM, KIHO
Art Unit
2884
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Abs Global Inc.
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
1m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
1439 granted / 1685 resolved
+17.4% vs TC avg
Minimal +4% lift
Without
With
+4.4%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 10m
Avg Prosecution
26 currently pending
Career history
1695
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
56.0%
+16.0% vs TC avg
§102
22.8%
-17.2% vs TC avg
§112
12.9%
-27.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1685 resolved cases

Office Action

§101 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957). A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101. Claims 1 – 11 and 14 – 16 are is/are rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 1 – 14 of prior U.S. Patent No. 12,168,779 B2. This is a statutory double patenting rejection. Allowable Subject Matter Claims 1 – 11 and 14 – 16 would be allowable if rewritten or amended to overcome the rejection(s) under Double Patenting, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: With respect to independent claim 1, Shapiro and Marks cited on PTO-892 are determined to be the closest art, teaching a method for producing a sexed semen sample, the method comprising: illuminating a cell with a focused beam of electromagnetic radiation; detecting a first fluorescence by the cell; determining a set of characteristics of the cell based on the fluorescence of the cell; identifying the cell as an undesired cell based on the set of characteristics; setting a timing signal for a kill laser wherein the timing signal causes the kill laser to emit a focused beam of electromagnetic radiation at the cell; firing the kill laser at the cell based on the timing signal; detecting a second fluorescence by the cell; but the prior art of record fails to teach or reasonably suggest: determining a type of event based on the second fluorescence, wherein the type of event is one of a slice, a kill, or a miss.. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KIHO KIM, Ph.D. whose telephone number is (571)270-1628. The examiner can normally be reached M-F: 8-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Makiya can be reached at (571)272-2273. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. KIHO KIM, Ph.D. Primary Examiner Art Unit 2884 /Kiho Kim/Primary Examiner, Art Unit 2884
Read full office action

Prosecution Timeline

Nov 25, 2024
Application Filed
Jul 22, 2026
Non-Final Rejection mailed — §101, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12699048
RAMAN-INFRARED SPECTROSCOPIC ANALYSIS MULTIFUNCTION MACHINE, AND MEASURING METHOD EMPLOYING RAMAN SPECTROSCOPY AND INFRARED SPECTROSCOPY
1y 12m to grant Granted Aug 04, 2026
Patent 12693154
PHOTODETECTOR
2y 11m to grant Granted Jul 28, 2026
Patent 12693436
SCINTILLATION CRYSTAL ARRAY, DETECTOR, MEDICAL IMAGING DEVICE, AND MANUFACTURING METHOD
2y 0m to grant Granted Jul 28, 2026
Patent 12693246
CRYSTAL PHASE INFORMATION EXTRACTION APPARATUS, CRYSTAL PHASE INFORMATION EXTRACTION METHOD AND STORAGE MEDIUM
2y 0m to grant Granted Jul 28, 2026
Patent 12691303
TECHNIQUES FOR DETECTING IN REAL-TIME PROTON BEAM THERAPY THREE DIMENSIONAL DOSE DELIVERED
2y 0m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
90%
With Interview (+4.4%)
1y 10m (~1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1685 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month